Home ›
Organizations ›
NFX
NFX
MI · Disease Research · EIN 821672519
1
Executives Disclosed
$6.9M
Annual Revenue
$10.3M
Total Assets
NFX has 1 executive with disclosed compensation. The highest-paid executive, Joyce Keller (EXECUTIVE DIRECTOR - PART YEAR), received peak total compensation of $170,192. The sector average for Disease Research executives is $215K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Joyce Keller | EXECUTIVE DIRECTOR - PART YEAR | $170K | $93K | 2017–2021 | 2.3x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2017 | 1 | $0 | $0 | $0 |
| 2018 | 1 | $129K | $129K | $129K |
| 2019 | 1 | $140K | $140K | $140K |
| 2020 | 1 | $170K | $170K | $170K |
| 2021 | 1 | $93K | $93K | $93K |
Email Alerts
Get notified about NFX
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.